Synovial Fibroblast 3.1: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 1 of 2) - Dataset (ID:20234)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
|---|---|---|---|---|---|---|---|---|---|---|---|
| RA1869 | 5z-7-oxozeaenol | 0.6 | uM | 1 | CTACK | 18.0 | 35 | ||||
| RA1869 | IKK16 | 2.0 | uM | 1 | CTACK | 17.0 | 56 | ||||
| N2759 | 5z-7-oxozeaenol | 0.6 | uM | 1 | CTACK | 17.0 | 87 | ||||
| N2759 | IKK16 | 2.0 | uM | 1 | CTACK | 15.0 | 68 | ||||
| RA1931 | 5z-7-oxozeaenol | 0.6 | uM | 1 | CTACK | 16.0 | 49 | ||||
| RA1931 | IKK16 | 2.0 | uM | 1 | CTACK | 21.5 | 58 | ||||
| N2586 | 5z-7-oxozeaenol | 0.6 | uM | 1 | CTACK | 17.0 | 58 | ||||
| N2586 | IKK16 | 2.0 | uM | 1 | CTACK | 16.5 | 46 | ||||
| RA1869 | Tofacitinib | 0.3 | uM | 1 | CTACK | 17.0 | 74 | ||||
| RA1869 | 1 | CTACK | 18.0 | 60 | |||||||
| N2759 | Tofacitinib | 0.3 | uM | 1 | CTACK | 16.0 | 55 | ||||
| N2759 | 1 | CTACK | 16.0 | 61 | |||||||
| RA1931 | Tofacitinib | 0.3 | uM | 1 | CTACK | 20.0 | 61 | ||||
| RA1931 | 1 | CTACK | 20.0 | 53 | |||||||
| N2586 | Tofacitinib | 0.3 | uM | 1 | CTACK | 19.0 | 42 | ||||
| N2586 | 1 | CTACK | 16.0 | 48 | |||||||
| 0 | CTACK | 17.0 | 71 | ||||||||
| 0 | CTACK | 15.0 | 59 | ||||||||
| 0 | CTACK | 15.0 | 45 | ||||||||
| 0 | CTACK | 16.0 | 50 | ||||||||
| 0 | CTACK | 16.0 | 42 | ||||||||
| 0 | CTACK | 20.0 | 30 | ||||||||
| RA2159 | 2 | CTACK | 21.0 | 49 | |||||||
| N2645 | 2 | CTACK | 16.0 | 59 | |||||||
| RA2708 | 2 | CTACK | 13.0 | 62 |